Filter by: patients
Home > Community Treatment Reports and Side Effects > Dabigatran Treatment Report
What is Dabigatran?

Dabigatran is an anticoagulant, thrombin inhibitor used for the prevention of stroke and systemic embolism in patients with nonvalvular atrial fibrillation and postoperative thromboprophylaxis in patients who have undergone total hip or knee replacement procedures.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Prevent blood clotting 7 3 Efficacy_cant_tell
Edema in feet 1 0
Support circulatory health 1 1 Efficacy_major
Antiphospholipid Antibody Syndrome 1 1 Efficacy_none
Irregular heartbeat (cardiac arrhythmia) 1 0
CCSVI (Chronic Cerebrospinal Venous Insufficiency) 1 1 Efficacy_moderate

See all 9 patients currently taking Dabigatran

Mouse over the table for more information

Reported Side Effects

Side effects as an overall problem

Severe
 0
Moderate
 1
Mild
 0
None
 6

Reported Dosages

  2 cap(s) daily 2 mg daily 150 mg daily 300 mg daily 350 mg daily
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 1 Number of Patients: 1  

Reported Stop Reasons

Why Patients Stopped Taking Dabigatran (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 2   Doctor's advice: 40%
Other 2   Other: 40%
Course of treatment ended 2   Course of treatment ended: 40%
Did not seem to work 1   Did not seem to work: 20%

See all 5 patients who’ve stopped taking Dabigatran

Reported Duration See details about how long patients take this treatment ▼

Currently Taking Dabigatran

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0

Stopped Taking Dabigatran

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0

Reported Adherence, Burden & Cost See details from patient evaluations ▼

Adherence

Taking treatment as prescribed

Adherence of Dabigatran

Always
 7 100%
Usually
 0 0%
Sometimes
 0 0%
Never
 0 0%

Burden

Difficulty being on treatment

Burden of Dabigatran

Very
 0 0%
Somewhat
 1 14%
A little
 2 29%
Not at all
 4 57%

Cost

Paid out of pocket

Cost of Dabigatran

$200+
 0 0%
$100-199
 1 20%
$50-99
 2 40%
$25-49
 1 20%
< $25
 1 20%

Report created on May 24, 2012.